Risk Communication Advisory Committee; Amendment of Notice, 65641 [2010-27060]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 206 / Tuesday, October 26, 2010 / Notices
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: October 21, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to the advisory committees.
[FR Doc. 2010–27063 Filed 10–25–10; 8:45 am]
Dated: October 21, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
BILLING CODE 4160–01–P
[FR Doc. 2010–27060 Filed 10–25–10; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Food and Drug Administration
[Docket No. FDA–2010–N–0001]
[Docket No. FDA–2010–N–0001]
Risk Communication Advisory
Committee; Amendment of Notice
AGENCY:
Food and Drug Administration,
HHS.
emcdonald on DSK2BSOYB1PROD with NOTICES
ACTION:
ACTION:
The Food and Drug Administration
(FDA) is announcing an amendment to
the notice of meeting of the Risk
Communication Advisory Committee.
This meeting was announced in the
Federal Register of September 20, 2010
(75 FR 57279). The amendment is being
made to reflect a change in the Agenda
portion of the document. There are no
other changes.
FOR FURTHER INFORMATION CONTACT: Lee
L. Zwanziger, Office of Policy, Planning
and Budget, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 32, Rm. 3278, Silver Spring,
MD 20993, 301–796–9151, FAX: 301–
847–8611, e-mail: RCAC@fda.hhs.gov,
or FDA Advisory Committee
Information Line, 1–800–741–8138
(301–443–0572 in the Washington, DC
area), code 8732112560. Please call the
Information Line for up-to-date
information on this meeting.
SUPPLEMENTARY INFORMATION: In the
Federal Register of September 20, 2010,
FDA announced that a meeting of the
Risk Communication Advisory
Committee would be held on November
8 and 9, 2010. On page 57280, in the
first column, the Agenda portion of the
document is changed to read as follows:
Agenda: On November 8 and 9, 2010,
the Committee will hear and discuss
developments in FDA’s ongoing
communications programs, such as
FDA’s Strategic Plan for Risk
Communication, FDA’s Transparency
Initiative, foodborne outbreaks and
related recall communications, and the
challenges of effectively communicating
with patients and caregivers about
appropriate use of medical devices
when a patient is prescribed a medical
device for home use.
18:09 Oct 25, 2010
AGENCY:
Food and Drug Administration,
HHS.
Notice.
VerDate Mar<15>2010
Tobacco Products Scientific Advisory
Committee; Notice of Meeting
Jkt 223001
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committee: Tobacco
Products Scientific Advisory
Committee.
General Function of the Committee:
To provide advice and
recommendations to the Agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on November 18, 2010, from 1 p.m.
until 5 p.m.
Location: FDA White Oak Conference
Center, 10903 New Hampshire Ave.,
Bldg. 31, rm. 1503, Silver Spring, MD
20993–0002. Information regarding
special accommodations due to a
disability, visitor parking, and
transportation may be accessed at:
https://www.fda.gov/
AdvisoryCommittees/default.htm; under
the heading ‘‘Resources for You’’ click
on ‘‘White Oak Conference Center
Parking and Transportation Information
for FDA Advisory Committee Meetings.’’
Contact Person: Caryn Cohen, Office
of Science, Center for Tobacco Products,
Food and Drug Administration, 9200
Corporate Blvd., Rockville, MD 20850,
1–877–287–1373 (choose Option 4),
e-mail: TPSAC@fda.hhs.gov, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area), code
8732110002. Please call the Information
Line for up-to-date information on this
meeting. A notice in the Federal
Register about last minute modifications
that impact a previously announced
advisory committee meeting cannot
always be published quickly enough to
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
65641
provide timely notice. Therefore, you
should always check the Agency’s Web
site and call the appropriate advisory
committee hot line/phone line to learn
about possible modifications before
coming to the meeting.
Agenda: On November 18, 2010, the
committee will (1) Receive an update on
the Menthol Report Subcommittee and
(2) receive and discuss presentations
regarding the data requested by the
committee at the March 30 and 31,
2010, meeting of the Tobacco Products
Scientific Advisory Committee.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before November 9, 2010.
Oral presentations from the public will
be scheduled between approximately 3
p.m. and 4 p.m. on November 18, 2010.
Those desiring to make formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before
November 1, 2010. Time allotted for
each presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by November 2, 2010.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Caryn Cohen
E:\FR\FM\26OCN1.SGM
26OCN1
]]>Agencies
[Federal Register Volume 75, Number 206 (Tuesday, October 26, 2010)]
[Notices]
[Page 65641]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-27060]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-N-0001]
Risk Communication Advisory Committee; Amendment of Notice
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA) is announcing an amendment
to the notice of meeting of the Risk Communication Advisory Committee.
This meeting was announced in the Federal Register of September 20,
2010 (75 FR 57279). The amendment is being made to reflect a change in
the Agenda portion of the document. There are no other changes.
FOR FURTHER INFORMATION CONTACT: Lee L. Zwanziger, Office of Policy,
Planning and Budget, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 32, Rm. 3278, Silver Spring, MD 20993, 301-796-9151, FAX:
301-847-8611, e-mail: RCAC@fda.hhs.gov, or FDA Advisory Committee
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC
area), code 8732112560. Please call the Information Line for up-to-date
information on this meeting.
SUPPLEMENTARY INFORMATION: In the Federal Register of September 20,
2010, FDA announced that a meeting of the Risk Communication Advisory
Committee would be held on November 8 and 9, 2010. On page 57280, in
the first column, the Agenda portion of the document is changed to read
as follows:
Agenda: On November 8 and 9, 2010, the Committee will hear and
discuss developments in FDA's ongoing communications programs, such as
FDA's Strategic Plan for Risk Communication, FDA's Transparency
Initiative, foodborne outbreaks and related recall communications, and
the challenges of effectively communicating with patients and
caregivers about appropriate use of medical devices when a patient is
prescribed a medical device for home use.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.
Dated: October 21, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2010-27060 Filed 10-25-10; 8:45 am]
BILLING CODE 4160-01-P
